Call us  +919820570188

408, Archana Building, Sector 17, Vashi, Navi Mumbai - 400703 INDIA. E-mail: [email protected]

Biotechnology Market

Information regarding market for various biotechnology products and services in world and in India is given in this section. Information is scattered and from various sources so a lot of variation is sometimes observed in the data.

Biotechnology in World

The global biotech industry, led by the United States, was $84.6 billion in 2010 and is expected to grow at a 7% CAGR to $103 billion by 2013.

According to a report by Frost and Sullivan (F&S), the size of the global biotechnology industry is set to reach $433 billion and

the global biosimilar industry to reach US$ 19.6 billion by 2015.

Share in Global Biotech Industry

United States            72.80%

Europe                       15.40%

Australia                    05.20%

Asia-Pacific               05.10%

Canada                      01.50%


US has 35% of the total biotech companies while Canada has 10% and Europe has 40% in the world.

Currently India’s share which is only $4 billion out of the $180 billion global biotech industry is negligible.

Number of Biotech Companies

                                                            OECD, December 2011             Ernst & Young’s (2012)

United States                                                6213                                       (2175)

France                                                           1359

Spain                                                             1095

European Union (Total of 18 countries)  5398                                                   (165)

Canada                                                                                                          (217)

Australia                                                                                                        (54)


The share of dedicated biotechnology firms out of the total number of all biotechnology firms ranges from 21% in the Netherlands to 87% in the Slovak Republic. The average for the reporting countries is 55%. Biotechnology firm size class data shows that the majority of firms have less than 50 employees. The share of firms with less than 50 employees ranges from 43% in Japan to 90% in New Zealand. The average for the reporting countries is 71%.

(Source: OECD, Biotechnology Statistics Database, December 2011).

Projection of Progressive Growth of Indian Biotech Industry

  • In 2010-11 the Indian Biotech industry registered 21.5% growth, touching $4 billion mark clocking Rs 18,399.34 Cr.
  • According  to  the  “India  in  Business”,  Ministry  of  External  Affairs,  Govt  of  India  the forecast for 2015 is  that the Indian biotech  industry would have an annual revenues in excess of  US$13 billion
  • The Biotechnology industry in India is expected to reach $11.6 billion by 2017-Global Industry Analysis
  • The Biotech Industry is expected to reach $20 billion (CAGR 20%) in 2020.
  • The Biotech Industry is expected to reach $100 billion by 2025.


According to report of Biospectrum Market share

                                    2011                                       2012-13

Biopharma                     61%                                        63.40%           Rs. 14,923 Crores

BioAgri                          14%                                       13.60%           Rs. 03,210 Crores

Bioservices                    20%                                       18.40%           Rs. 04,329 Crores

BioIndustrial                  04%                                        03.28%           Rs. 00,772 Crores

Bioinformatics               01%                                       01.23%           Rs. 00,290 Crores

Total                                                                                              Rs. 23,524 Crores


Indian Biopharma Sector

Vaccines                   43% Share

Diagnostics               16% Share

Therapeutics             13% Share

The current estimated worldwide market breakdown for Nanobiotechnology is:

U.S. at 65%,

Europe at 20%,

Japan at 10%, and

the rest of the world at 5%.

Market for Different Biotech Products and Services (World and India)

  Product / Service World India
  Biopharmaceuticals worth about US$137 billion today, is expected to touch US$319 billion by 2020 Share miniscule 1.4 percent (at around US$2 billion)
  Vaccines Expected to be $10 billion in 2010 Indian vaccine market US$900 million in 2011-12 and targets US$4.6 billion revenue by 2017.

Animal Vaccine market $60-70 million in 2011-12

  Bioinformatics Market was valued at $2.9 billion in 2012 and is poised to reach $7.5 billion by 2017 $55 million in 2012.
  Enzymes   Rs 375 crore with growth rate of 17 percent for the year 2005-06
  Nanobiotechnology $3 billion in 2008.

Around 500 compaies involved in Nanobiotechnology work.  

  Clinical Trials Clinical Research Market expected to be $126 billion by 2016. $500 million in 2013, Projected to be $1 billion by 2016.
  Synthetic Biology $1.1 billion in 2010 and expected to be $10.8 billion in 2016.  



Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>